4.4 Article

Deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy

Journal

JOURNAL OF HUMAN GENETICS
Volume 61, Issue 7, Pages 663-667

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/jhg.2016.28

Keywords

-

Funding

  1. Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry
  2. Grants-in-Aid for Scientific Research [15H06883, 25460666] Funding Source: KAKEN
  3. Medical Research Council [MC_PC_12020] Funding Source: researchfish
  4. MRC [MC_PC_12020] Funding Source: UKRI

Ask authors/readers for more resources

Few cases of dystrophinopathy show an asymptomatic phenotype with mutations in the 5' (exons 3-7) hot spot in the Duchenne muscular dystrophy (DMD) gene. Our patient showed increased serum creatine kinase levels at 12 years of age. A muscle biopsy at 15 years of age led to a diagnosis of Becker muscular dystrophy. The patient showed a slight decrease in cardiac function at the age of 21 years and was administered a beta-blocker, but there was no muscle involvement even at the age of 27 years. A deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene was detected, and dystrophin protein expression was similar to 15% that of control level. We propose that in-frame deletion of exons 3-9 may produce a functional protein, and that multiexon skipping therapy targeting these exons may be feasible for severe dystrophic patients with a mutation in the 5' hot spot of the DMD gene.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available